The Telegraph in an exclusive interview. "Our exports to COVAX will recommence again in October, initially these supplies will be small but by January 2022, once we have satisfied domestic demands – people forget that India is still a lower-middle-income country – we will see large volumes go to COVAX," Chief Executive Adar Poonawalla said.
Prime Minister Boris Johnson administration’s refusal to recognise India-made doses of the Oxford AstraZeneca vaccine is causing “total chaos", Poonawalla said. “It is total chaos.
I am calling on all countries to work together, harmoniously, to sign a mutually agreed pact. We can at least acknowledge a certification programme using vaccines approved by the World Health Organization (WHO),"